Recent developments in gastroenterology

British Medical Journal

Volumn 325, Issue 7377, 2002, Pages 1399-1402

  Moayyedi, Paul ^a   Ford, Alex ^b  

^a CITY HOSPITAL   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; APC PROTEIN; CORTICOSTEROID; CYCLIN D1; CYCLOSPORIN; DNA; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MICROSPHERE; MONOCLONAL ANTIBODY; PROTON PUMP INHIBITOR; SEROTONIN 3 ANTAGONIST; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; AGED; BARRETT ESOPHAGUS; CANCER RISK; CANCER SCREENING; CAPSULE ENDOSCOPY; CHROMOSOME 16; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROHN DISEASE; DIGESTIVE SYSTEM CANCER; DISEASE PREDISPOSITION; DYSPEPSIA; ESOPHAGUS CARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROINTESTINAL ENDOSCOPY; GENE MUTATION; GENETIC PREDISPOSITION; HEALTH CARE COST; HELICOBACTER PYLORI; HEMOCHROMATOSIS; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; IRRITABLE COLON; ISCHEMIC COLITIS; MAJOR CLINICAL STUDY; MALE; MICROCAPSULE; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY; STOMACH CANCER; TELEMETRY; ULCERATIVE COLITIS; VIDEORECORDER;

EID: 0037079428     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.325.7377.1399     Document Type: Review

References (31)

1. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347-53.
2. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8.
3. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
4. Mason J, Feltbower R, Crocombe W, Duffett S, Axon ATR, Drummond, et al. The effect of population H pylori screening and treatment on dyspepsia in the community: An economic analysis of a randomised controlled trial. Aliment Pharmacol Ther 2002;16:559-68.
5. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 1998;317:559-65.
6. Traverso G, Shuber A, Levin B, Johnson C, Olsson L, Schoetz DJ, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-20.
7. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: Baseline findings of a UK multicentre randomised trial. Lancet 2002;359:1291-2000.
8. Schoenfeld P, Lipscomb S, Crook J, Dominguez J, Butler J, Holmes L, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: A randomized trial. Gastroenterology 1999;117:312-8.
9. Imperiale T, Wagner D, Lin C, Rogge J, Ransohoff D. Risk of advanced neoplasms in asymptomatic adults according to the distal colorecial findings. N Engl J Med 2000;343:169-74.
10. Lieberman D, Weiss D, Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
11. Rembacken BJ, Fujii T, Cairns A, Dixon MF, Yoshida S, Chalmers DM, et al. Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet 2000;355:121-4.
12. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000;405:417.
13. Appleyard M, Fireman Z, Glukhovsky A, Jacob H, Shreiver R, Kadirkamanathan S, et al. A randomised trial comparing wireless capsule endoscopy with push enteroscopy for the detection of small-bowel lesions. Gastroenterology 2000;119:1431-8.
14. Halligan S, Fenlon HM. Science, medicine, and the future: Virtual colonoscopy. BMJ 1999;319:1249-52.
15. Fenlon HM, Nunes DP, Schroy PC 3rd, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med 1999;341:1496-503.
16. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, et al. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. BMJ 2000;321:659-64.
17. Delaney BC, Innes MA, Deeks J, Wilson S, Oakes R, Moayyedi P, et al. Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2001;(3):CD001961.
18. McColl KEL, Murray LS, Gillen D, Walker A, Wirz A, Fletcher J, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. BMJ 2002;324:999-1002.
19. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection - The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002;16:167-80.
20. American Gastroenterological Association medical position statement: Evaluation of dyspepsia. Gastroenterology 1998;114:579-81.
21. Moayyedi P, Bardhan KD, Young L, Dixon MF, Brown L, Axon ATR. The effect of Helicobacter pylori eradication on reflux symptoms in gastro-esophageal reflux disease in patients: A randomised controlled trial. Gastroenterology 2001;121:1120-6.
22. Filipi CJ, Lehman GA, Rothstein RI, Raijman I, Stiegmann GV, Waring P, et al. Transoral, flexible endoscopic suturing for treatment of GERD: A multicentre trial. Gastrointestinal Endoscopy 2001;53:416-22.
23. Feretis C, Benakis P, Dimopoulos C, Dailianas A, Filalithis P, Stamou KM, et al. Endoscopic implantation of plexiglas (PMMA) microspheres for the treatment of GERD. Gastrointest Endosc 2001;55:423-6.
24. Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe M, et al. The Stretta procedure for the treatment of GERD: 6 And 12 month follow-up of the US open label trial. Gastrointestinal Endosc 2002;55:145-56.
25. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-based trial. Lancet 2000;355:1035-40.
26. Freidel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosetron. Gastroenterology 2001;120:557-60.
27. Horton R. Lotonex and the FDA: A fatal erosion of integrity. Lancet 2001;357:1544-5.
28. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001;120:652-8.
29. National Institute of Clinical Excellence. Guidance on the Use of Infliximat for Crohn's Disease. London: NICE, 2002. (Technology appraisal guidance No 40.)
30. Ehrenpreis ED, Kane SV, Cohen LB, Cohen RD, Hanaver SB, et al. Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial. Gastroenterology 1999;117:1271-7.
31. D'Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans I., et al. Intravenous cyclosporin versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323-9.